Hepatocellular carcinoma: An epidemiologic view

Journal of Clinical Gastroenterology

Volumn 35, Issue 5 SUPPL., 2002, Pages

  El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Hepatitis; Hepatocellular carcinoma

Indexed keywords

AFLATOXIN B1; ALCOHOL;

AGE; ALCOHOL LIVER CIRRHOSIS; CANCER INCIDENCE; CANCER MORTALITY; CHINA; CONFERENCE PAPER; DEMOGRAPHY; DEVELOPING COUNTRY; DIABETES MELLITUS; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; TAIWAN; UNITED STATES;

AFLATOXINS; CARCINOMA, HEPATOCELLULAR; COMPUTER GRAPHICS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; WORLD HEALTH;

EID: 0036841697     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200211002-00002     Document Type: Conference Paper

References (38)

1. Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
2. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;ii:1129-33.
3. Di Bisceglie AM. Malignant tumors of the liver. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 8th Ed. Philadelphia: Lippincott-Raven Publishers. 1999:1281-304.
4. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 1999;13:519-28.
5. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatotogy 1997;26:34S-8S.
6. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
7. Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopathological follow-up of posttransfusion hepatitis. Hepatology 1991;14:969-74.
8. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
9. Kiyosawa K, Tanaka E, Sodeyama. Hepatitis C virus and hepatocellular carcinoma, In: Reesnick HW, ed. Hepatitis C Virus. Vol. 62. Current Studies in Hematology and Blood Transfusion. Basel: Karger, 1998:161-80.
10. Yoshida H., Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999;131:174-81.
11. Poynard T, Bedossa P, Opolon P, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
12. Poynard T, Aubert A, Lazizi Y, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 1990;13:869-901.
13. El-Serag HB, Richardson P, Everhart JE. The role of diabetes in hepatocellular carcinoma among veterans: A case-control study. Am J Gastroenterol 2001;96:2462-7.
14. McGlynn KA, Tsao L, Hsing AW, et al. International trends and patterns of primary liver cancer. Int J Cancer 2001;94:290-6.
15. World Health Organization. The international classification of diseases. 9th revision. Clinical Modification, 3rd Ed. DHHS Publication No. (PHS) 89-1260. Washington, DC: Public Health Service, US Government Printing Office, March 1989.
16. World Health Organization. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization, 1976.
17. El-Serag HB. Global epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001;5:87-107.
18. Okuda K, Fujimoto J, Hanai A. et al. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
19. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
20. Deuffic S, Poynard T, Valleron A. Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepatol 1999;6:411-3.
21. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, Vol. VII. Lyon: IARC Scientific Publication No. 143, International Agency for Research on Cancer, 1997.
22. Muir C, Waterhouse J, Mack T, et al. Cancer Incidence in Five Continents, Vol. V. Lyon: IARC Sci Publ No. 88, International Agency for Research on Cancer. 1987.
23. Yu S. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 1995;10:674-82.
24. El-Serag HB, Mason AC, Key CR. Temporal trends in survival of patients with hepatocellular carcinoma in the US. Hepatology 2001;33:62-5.
25. Everhart JE, Hoofnagle. Hepatitis B-related end stage liver disease. Gastroenterology 1992;103:1692-4.
26. Grant BF, Zobeck TS, Pickering RP. Liver Cirrhosis Mortality in the United States, 1973-1978. US Department of Health and Human Services, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse and Alcoholism, 1990.
27. de Franchis R. Treatment of bleeding esophageal varices: A meta-analysis. Scand J Gastroenterol 1994;24(Suppl 207):29-33.
28. El-Serag HB, Everhart JE. Improved survival following variceal hemorrhage over an 11-year period in the Department of Veteran Affairs. Am J Gastroenterol 2000;95:3566-73.
29. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-30.
30. Hassan M, Fromm A, Patt YZ, et al. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002;35:266-9.
31. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-7.
32. Verbaan H, Hoffmann G, Lindgren S, et al. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol 1998;33:650-5.
33. Lawson DH, Gray JMB, McKillop C, et al. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986;61:945-55.
34. Lagiou P, Kuper H, Stuver SO. et al. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-9.
35. Lu SN, Lin, TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-5.
36. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-9.
37. Moore MA, Park CB, Tsuda H. Implications of the hyperinsulinemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev 1998;7:89-107.
38. Gentile S, Loguercio C, Marmo R, et al. Incidence of altered glucose tolerance in cirrhosis. Diabetes Res Clin Pract 1993;22:37-44.